Evaluating the dissemination of evidence-based practices in substance use treatment: A cluster-randomized clinical trial of Colombo Plan's Innovative professional training model

IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Contemporary Clinical Trials Communications Pub Date : 2025-02-11 DOI:10.1016/j.conctc.2025.101452

Alvaro Vergés , Rodrigo Portilla Huidobro , Marta Oliva , Víctor Landa

{"title":"Evaluating the dissemination of evidence-based practices in substance use treatment: A cluster-randomized clinical trial of Colombo Plan's Innovative professional training model","authors":"Alvaro Vergés , Rodrigo Portilla Huidobro , Marta Oliva , Víctor Landa","doi":"10.1016/j.conctc.2025.101452","DOIUrl":null,"url":null,"abstract":"<div><div>The training of professionals who work in the treatment of substance use disorders is a fundamental aspect for the dissemination of evidence-based practices that ensure the quality of the treatment delivered to patients. Colombo Plan has developed a training model that allows effective, rapid, and scalable dissemination. However, this model does not have an empirical evaluation of its results to date. This project seeks to evaluate the dissemination model through a cluster-randomized clinical trial with a parallel superiority design, in which 27 treatment centers will be randomly assigned to training + action plan and technical advice, training only, or control without training, action plan or advice. The results of this study will inform public policy regarding substance use treatment at the national level and will help improve efforts by Colombo Plan at dissemination of evidence-based practices.</div></div>","PeriodicalId":37937,"journal":{"name":"Contemporary Clinical Trials Communications","volume":"44 ","pages":"Article 101452"},"PeriodicalIF":1.4000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary Clinical Trials Communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2451865425000262","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

Abstract

The training of professionals who work in the treatment of substance use disorders is a fundamental aspect for the dissemination of evidence-based practices that ensure the quality of the treatment delivered to patients. Colombo Plan has developed a training model that allows effective, rapid, and scalable dissemination. However, this model does not have an empirical evaluation of its results to date. This project seeks to evaluate the dissemination model through a cluster-randomized clinical trial with a parallel superiority design, in which 27 treatment centers will be randomly assigned to training + action plan and technical advice, training only, or control without training, action plan or advice. The results of this study will inform public policy regarding substance use treatment at the national level and will help improve efforts by Colombo Plan at dissemination of evidence-based practices.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Contemporary Clinical Trials Communications Pharmacology, Toxicology and Pharmaceutics-Pharmacology

CiteScore

2.70

自引率

6.70%

发文量

146

审稿时长

20 weeks

期刊介绍： Contemporary Clinical Trials Communications is an international peer reviewed open access journal that publishes articles pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from a wide range of disciplines including medicine, life science, pharmaceutical science, biostatistics, epidemiology, computer science, management science, behavioral science, and bioethics. Contemporary Clinical Trials Communications is unique in that it is outside the confines of disease specifications, and it strives to increase the transparency of medical research and reduce publication bias by publishing scientifically valid original research findings irrespective of their perceived importance, significance or impact. Both randomized and non-randomized trials are within the scope of the Journal. Some common topics include trial design rationale and methods, operational methodologies and challenges, and positive and negative trial results. In addition to original research, the Journal also welcomes other types of communications including, but are not limited to, methodology reviews, perspectives and discussions. Through timely dissemination of advances in clinical trials, the goal of Contemporary Clinical Trials Communications is to serve as a platform to enhance the communication and collaboration within the global clinical trials community that ultimately advances this field of research for the benefit of patients.